Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer. - Wu YS; Burger EA; Holmboe F; Bangum M; Oteiza F; Bugge C; Sæther EM; Aas E (PharmacoEconomics - open, 2026)